StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research note released on Monday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Stock Performance
Shares of SRNE opened at $0.00 on Monday. The business has a 50-day moving average of $0.01 and a 200-day moving average of $0.01. Sorrento Therapeutics has a 1 year low of $0.00 and a 1 year high of $0.25.
About Sorrento Therapeutics
Featured Articles
- Five stocks we like better than Sorrento Therapeutics
- Best Stocks Under $10.00
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- Investing in Commodities: What Are They? How to Invest in Them
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- Options Trading – Understanding Strike Price
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.